Common Hawthorn

Taxonomy

Common Hawthorn (Crataegus monogyna) is a species within the Rosaceae family, belonging to the genus Crataegus, and is classified under the order Rosales, class Eudicots, division Magnoliophyta, and kingdom Plantae.

The following table shows the full taxonomy of this plant.

Morphology

Common Hawthorn (Crataegus monogyna) is a deciduous shrub or small tree with thorny branches, ovate to elliptic leaves with serrated edges, and clusters of white to pink flowers that bloom in spring, followed by red, berry-like fruits in autumn.

Distribution

Common Hawthorn (Crataegus monogyna) is native to southern and central Europe, including regions such as the Mediterranean, the British Isles, and parts of western Asia, with a range extending into northern Africa.

Traditional Uses

Common Hawthorn has been traditionally used in herbal medicine to support cardiovascular health, alleviate mild anxiety, and promote digestive wellness through its mild sedative and antispasmodic properties.

Medicinal Systems

In traditional medicinal systems such as Traditional Chinese Medicine, Ayurveda, and European herbalism, Common Hawthorn has been widely used for its cardiovascular, digestive, and nervine benefits.

Phytochemistry

Common Hawthorn (Crataegus monogyna) contains bioactive compounds such as flavonoids, proanthocyanidins, triterpenes, and organic acids, which contribute to its traditional use in herbal medicine for cardiovascular and nervous system support.

Pharmacology

Common Hawthorn (Crataegus monogyna) exhibits pharmacological properties characterized by cardiovascular support, sedative effects, and mild anti-inflammatory actions, primarily through its influence on the heart's function and central nervous system.

Medicinal Uses

Common Hawthorn is used to treat conditions such as cardiovascular disorders, digestive issues, insomnia, anxiety, and mild depression.

Preparations

Common Hawthorn is used to prepare tinctures, decoctions, and infusions that are traditionally employed in herbal medicine for their cardiovascular, digestive, and mild sedative properties.

Safety

While common hawthorn is generally considered safe when used in recommended doses, it may cause mild side effects such as gastrointestinal discomfort, dizziness, or headaches, and in some cases, it can interact with medications affecting the heart or blood pressure.

Evidence

Clinical evidence for Common Hawthorn (Crataegus monogyna) primarily supports its use in the management of cardiovascular conditions, particularly in alleviating symptoms of mild to moderate heart failure and angina, with some studies suggesting potential benefits in regulating heart rate and improving cardiac output.

Cultivation

Common Hawthorn (Crataegus monogyna) is typically cultivated in well-drained soil in full sun, requiring minimal pruning and care, though it thrives best in temperate climates with moderate rainfall.

Processing

Common Hawthorn berries are typically harvested when fully ripe, usually in late summer to early autumn, and then processed through drying, crushing, or maceration to extract their active compounds for use in herbal preparations.

Identification

Common Hawthorn (Crataegus monogyna) is a deciduous shrub or small tree identifiable by its thorny branches, oval-shaped leaves with serrated edges, and clusters of white flowers that develop into red, berry-like fruits in the fall.

Sustainability

The sustainability of Common Hawthorn (Crataegus monogyna) as a herbal medicine depends on responsible harvesting practices, conservation efforts, and the preservation of its natural habitat to ensure its long-term availability and ecological balance.

Related

Common Hawthorn (Crataegus monogyna) is closely related to other species in the genus Crataegus, including Crataegus laevigata, Crataegus oxyacantha, and Crataegus monogyna subsp. rufa, which share similar medicinal properties and ecological roles.

Research Gap

While there is existing research on the pharmacological properties of Common Hawthorn, there remains a lack of comprehensive, large-scale clinical trials specifically evaluating its efficacy and safety in treating cardiovascular conditions, particularly in modern therapeutic contexts.

References

1. Bahorun, Trotin, Pommery, Vasseur, Pinkas. "Antioxidant activities of Crataegus monogyna extracts." Planta medica
2. Bahorun, Gressier, Trotin, Brunet, Dine, Luyckx, Vasseur, Cazin, Cazin, Pinkas. "Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations." Arzneimittel-Forschung
3. Ahumada, Sáenz, García, De La Puerta, Fernandez, Martinez. "The effects of a triterpene fraction isolated from Crataegus monogyna Jacq. on different acute inflammation models in rats and mice. Leucocyte migration and phospholipase A2 inhibition." The Journal of pharmacy and pharmacology
4. Sáenz, Ahumada, García. "Extracts from Viscum and Crataegus are cytotoxic against larynx cancer cells." Zeitschrift fur Naturforschung. C, Journal of biosciences
5. Anıl, Ersoy, Tavlı, Daci, Topal, Dönmez, Demirci Kayıran, Eroğlu Özkan, Melikoğlu. "Innovative findings on three endemic Crataegus spp. from Türkiye: flavonoid-enriched extracts with cardiovascular benefits demonstrated by reduction of oxidative and inflammatory markers on rat aorta tissue." Natural product research